A webinar in the "Controversies in Urology" series
Primum non nocere - a medical dictum that embodies the controversy around screening for prostate cancer. Prostate cancer is the commonest male cancer in the UK, and this webinar brings together three of the biggest names in this subject to discuss recent developments, including the impact of pre-biopsy MRI on the screening paradigm.
Contributors: Peter Albertsen, Freddie Hamdy & Mark Emberton.
Duration: 1 hour.
This event was approved for CME by BAUS with 1 points awarded
Organised by: Bev Tomkins of BAUS
Phone Number: +44 (0)20 8051 6703
This event is free for BAUS members. For non-members, please find a list of tickets for this event below.